BRIEF-GlaxoSmithKline's HIV medicine Tivicay approved in the European Union

Tue Jan 21, 2014 6:55am EST

Related Topics

Jan 21 (Reuters) - GlaxoSmithKline Plc : * VIIV Healthcare's new HIV medicine Tivicay Tm (Dolutegravir) is approved in Europe * European commission has approved Tivicaytm for treatment of HIV infected adults, adolescents above 12 years * European regulatory authorisation to market the medicine in each member state of the European union * Source text for Eikon: * For more news, please click here